Literature DB >> 21955237

Schistosomiasis and pulmonary hypertension.

Caio Julio Cesar Dos Santos Fernandes1, Carlos Viana Poyares Jardim, André Hovnanian, Susana Hoette, Luciana Kato Morinaga, Rogerio Souza.   

Abstract

Schistosomiasis is one of the most prevalent chronic infectious diseases in the world. One of its most severe complications, pulmonary hypertension, occurs in up to 5% of patients with hepatosplenic schistosomiasis. The prevalence of schistosomiasis is so overwhelming that schistosomiasis-associated pulmonary hypertension (Sch-PH) may be the most prevalent cause of pulmonary hypertension around the world. Multiple pathways have been described as potential mechanisms of disease in Sch-PH, such as egg embolism, inflammatory disease or pulmonary blood overflow. The possible physiopathological mechanisms will be discussed in this article, as well the disease's clinical course and response to the treatment available.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955237     DOI: 10.1586/ers.11.58

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  9 in total

1.  Waiting to inhale: An exploratory review of conditions that may predispose to pulmonary hypertension and right heart failure in persons exposed to household air pollution in low- and middle-income countries.

Authors:  Gerald S Bloomfield; David K Lagat; O Constantine Akwanalo; E Jane Carter; Njira Lugogo; Rajesh Vedanthan; Eric J Velazquez; Sylvester Kimaiyo; Charles B Sherman
Journal:  Glob Heart       Date:  2012-09-01

2.  Pulmonary artery pressure, gender, menopause, and pregnancy in schistosomiasis-associated pulmonary hypertension.

Authors:  Anderson C Armstrong; Ângela M P Bandeira; Luis C L Correia; Humberto C O Melo; Carlos A M Silveira; Eugênio Albuquerque; Jeová C Moraes; Antônio M L Silva; João A C Lima; Dário C Sobral Filho
Journal:  Arq Bras Cardiol       Date:  2013-07-02       Impact factor: 2.000

Review 3.  Schistosomiasis Pulmonary Arterial Hypertension.

Authors:  Jean Pierre Sibomana; Aloma Campeche; Roberto J Carvalho-Filho; Ricardo Amorim Correa; Helena Duani; Virginia Pacheco Guimaraes; Joan F Hilton; Biruk Kassa; Rahul Kumar; Michael H Lee; Camila M C Loureiro; Sula Mazimba; Claudia Mickael; Rudolf K F Oliveira; Jaquelina S Ota-Arakaki; Camila Farnese Rezende; Luciana C S Silva; Edford Sinkala; Hanan Yusuf Ahmed; Brian B Graham
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

Review 4.  Clinical Spectrum of Schistosomiasis: An Update.

Authors:  Cristina Carbonell; Beatriz Rodríguez-Alonso; Amparo López-Bernús; Hugo Almeida; Inmaculada Galindo-Pérez; Virginia Velasco-Tirado; Miguel Marcos; Javier Pardo-Lledías; Moncef Belhassen-García
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

Review 5.  Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases.

Authors:  Masashi Ikutani; Susumu Nakae
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

6.  Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension.

Authors:  Susana Hoette; Claudia Figueiredo; Bruno Dias; Jose Leonidas Alves; Francisca Gavilanes; Luis Felipe Prada; Dany Jasinowodolinski; Luciana Tamie Kato Morinaga; Carlos Jardim; Caio Julio Cesar Fernandes; Rogério Souza
Journal:  BMC Pulm Med       Date:  2015-10-12       Impact factor: 3.317

7.  Quality of life as a prognostic marker in pulmonary arterial hypertension.

Authors:  Caio J C S Fernandes; Barbara C S Martins; Carlos V P Jardim; Rozana M Ciconelli; Luciana K Morinaga; Ana Paula Breda; Susana Hoette; Rogério Souza
Journal:  Health Qual Life Outcomes       Date:  2014-08-30       Impact factor: 3.186

8.  Pulmonary Hypertension in General Cardiology Practice.

Authors:  Daniela Calderaro; José Leonidas Alves Junior; Caio Júlio César Dos Santos Fernandes; Rogério Souza
Journal:  Arq Bras Cardiol       Date:  2019-10-10       Impact factor: 2.000

Review 9.  Host Immunity and Inflammation to Pulmonary Helminth Infections.

Authors:  Jill E Weatherhead; Pedro Gazzinelli-Guimaraes; John M Knight; Ricardo Fujiwara; Peter J Hotez; Maria Elena Bottazzi; David B Corry
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.